🇺🇸 FDA
Patent

US 10780095

Compositions and methods for treating disorders of circadian and diurnal rhythms using prokineticin 2 agonists and antagonists

granted A61KA61K31/357A61K31/4025

Quick answer

US patent 10780095 (Compositions and methods for treating disorders of circadian and diurnal rhythms using prokineticin 2 agonists and antagonists) held by The Regents of the University of California expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/357, A61K31/4025, A61K31/4184, A61K31/454